This study explores the role of CD133 expression in gastric cancer progression, independent of Helicobacter pylori infection. CD133, a marker associated with cancer stem cells, was evaluated for its potential as a biomarker in gastric cancer. The research highlights that high CD133 expression correlates with advanced stages of gastric cancer,
